Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%

Low‐dose mifepristone (< 25 mg) vs levonorgestrel 1.5 mg

Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception

Low‐dose mifepristone (< 25 mg) leads to lower specific side effect ‐ spotting/bleeding after treatment compared with levonorgestrel 1.5 mg (high certainty).

1 finding from 1 review

Interventions for emergency contraception 2019 · Cochrane Headline outcomes only
RR 0.61 [0.54, 0.69]
5 studies · 4598 participants
High

Mid‐dose mifepristone (25 mg‐50 mg) vs low‐dose mifepristone (< 25 mg)

Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception

Mid‐dose mifepristone (25 mg‐50 mg) leads to higher specific side effects ‐ spotting/bleeding after treatment compared with low‐dose mifepristone (< 25 mg) (high certainty).

1 finding from 1 review

Interventions for emergency contraception 2019 · Cochrane Headline outcomes only
RR 1.85 [1.55, 2.2]
11 studies · 5078 participants
High